Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
about
Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaIsoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsImpact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001Aetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional studyHIV and Tuberculosis: a Deadly Human SyndemicEffect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.Tuberculosis and HIV: a partnership against the most vulnerable.Comparative radiological features of disseminated disease due to Mycobacterium tuberculosis vs non-tuberculosis mycobacteria among AIDS patients in Brazil.AIDS-related tuberculosis in Rio de Janeiro, Brazil.Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan AfricaTrends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil.Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004.Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV/AIDS.Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.Antiretroviral therapy for tuberculosis control in nine African countries.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Timing of antiretroviral therapy for HIV in the setting of TB treatment.Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana.Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.Treatment outcomes of patients with HIV and tuberculosis.Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis.Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.Quantitative impact of human immunodeficiency virus infection on tuberculosis dynamics.Treatment of latent tuberculosis infection in HIV: shorter or longer?Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China[Factors associated with TB/HIV coinfection: evidence from notification data in the State of Amazonas, Brazil, 2001-2012].Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic.Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital.Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006.
P2860
Q21521430-ED7E75E9-B35D-4058-AB13-67ED8BFBDA12Q26778385-2AF598E4-4589-4489-AB2B-6200D15E85F2Q28469286-E967CB6D-8507-4BC4-BA2F-781D1314BAC9Q28535816-FEC28839-FCA5-4E05-B263-6F7E2E8D9710Q30052157-AAAF9B15-4E43-459B-982A-EF5C9CE70094Q30240445-1E9125C5-1549-4A1C-8627-A3B1B9B98AD3Q30336184-AAD5C015-4150-4F65-93ED-467994DA19BAQ33321960-FCBA5747-AA19-40CF-BD44-4EE1D33B8A6AQ33368050-DA592A83-B057-4FA6-9201-88460EB36445Q33580153-986B8BF4-1472-4A95-8F07-B3361FFAE2E7Q33717183-6F9B67E4-AD9A-4EFC-94F3-BF60FA401BC8Q33726957-F3AB89CE-893B-426B-BF10-D10EA6D9270FQ33920318-B8CB6DCB-27B5-4C9D-9816-4A85C85E5C78Q33997536-BBD6BE5E-6D5A-480A-BD33-56C94E439D64Q34011244-9C6E7A96-F7D8-4590-A69B-F7D5557C51F1Q34213437-4A99AE87-F7AC-47BE-BDFD-E2D45F6D67F9Q34320245-BEC49828-BCD3-4A16-A8CD-DE058B2B297BQ34387168-BDB9FD66-FEF6-4C12-B98E-7F6DD81259EDQ34475542-1A821E76-83C7-4880-9A9B-0E3E0978A2EFQ34666176-00ACB3F1-C578-4DB1-B9FC-89F57AB3B780Q34717877-556EBFBA-29B8-4335-857C-229FE6225F68Q34717889-200E7116-B9B6-44D0-890D-12BCC36DA580Q34732206-AF32EA9B-9688-4361-A207-0D8F5EB55805Q35120388-6F676CD2-8C2B-48C1-A94C-CC6F9D66D40FQ35173497-462B34AB-1F07-4AAA-8B61-B9132A9F92A5Q35835660-8DA187C1-2039-4299-8984-399AE632EEF2Q35855154-D1C931F3-DD3D-4662-91F7-5D007BD03B44Q35867166-EAA48481-E92E-46B9-B441-F17FCC577647Q35870509-0F31D2F0-09A5-490B-B7FD-037117014031Q35905025-F3ED880C-7C67-4619-9F06-BCD31668D5BFQ36102821-98E56100-98C6-4CE7-B78E-7DD8DDF38911Q36137225-6C65A515-C427-41E5-B5D9-218B2264033FQ36328236-832ACB20-42CE-4650-89C7-2DBA58A49A2FQ36405541-DC2D2D80-9B2D-4507-8FBE-1542637E66B6Q36509003-608ECFC3-38DF-4C4F-A218-9DBB0C6ECBDDQ36877233-F7484CE3-85A0-442E-89D7-84FA7423431AQ36877237-10A20D9D-7CA8-4044-900B-8549C0E770B6Q36899433-6FCD4EF8-201C-429C-AF7E-E34DD52FD57DQ36973623-9F5EF72D-1A7A-48D9-9B69-793E535E0124Q36997187-8FF6D805-43DA-4EAA-9280-10C955EED350
P2860
Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@en
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@nl
type
label
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@en
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@nl
prefLabel
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@en
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@nl
P2093
P2860
P356
P1476
Reduced risk of tuberculosis a ...... active antiretroviral therapy.
@en
P2093
Ana Maria Felix de Pinho
Lee H Harrison
Mauro Schechter
P2860
P304
P356
10.1086/338641
P407
P577
2002-01-07T00:00:00Z